首页 › 弥漫性大B细胞淋巴瘤 › 内布拉斯加州 › Omaha
Omaha NE 弥漫性大B细胞淋巴瘤临床试验
9项针对 弥漫性大B细胞淋巴瘤的研究正在 Omaha及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
招募中2 期
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 距离 9 英里
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
招募中2 期
- University Of Nebraska Medical Center ( Site 0110), Omaha
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
招募中2/3 期
- Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0177), Omaha
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
招募中1 期
- The University of Nebraska Medical Center, Omaha
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
招募中2 期
- Nebraska Cancer Specialists, Omaha
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- University of Nebraska Medical Center, Omaha
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- University of Nebraska Medical Center (UNMC), Omaha
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
招募中1/2 期
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
招募中2 期
- Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
其他城市的 弥漫性大B细胞淋巴瘤试验
- New York City, NY21 项研究
- Baldwin Park, CA19 项研究
- Chicago, IL18 项研究
- Houston, TX17 项研究
- Los Angeles, CA17 项研究
- Milwaukee, WI16 项研究
- Boston, MA16 项研究
- Philadelphia, PA15 项研究
- Portland, OR15 项研究
- Durham, NC14 项研究
- Nashville, TN14 项研究
- Dallas, TX13 项研究
Omaha的其他研究
- 前列腺癌28 项研究
- 非小细胞肺癌25 项研究
- 乳腺癌23 项研究
- 癌症（所有类型）19 项研究
- 结直肠癌19 项研究
- 多发性骨髓瘤16 项研究
- 卵巢癌15 项研究
- 胰腺癌14 项研究
- 转移性癌症14 项研究
- 非霍奇金淋巴瘤14 项研究
- 肺癌13 项研究
- 心力衰竭13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。